Hepatic Manifestations of Lymphoproliferative Disorders.
Hepacivirus
/ physiology
Hepatitis B virus
/ physiology
Hepatitis B, Chronic
/ etiology
Hepatitis C, Chronic
/ etiology
Hodgkin Disease
/ complications
Humans
Liver Diseases
/ etiology
Liver Neoplasms
/ etiology
Lymphoma, Non-Hodgkin
/ complications
Lymphoproliferative Disorders
/ complications
Opportunistic Infections
/ complications
Organ Transplantation
/ adverse effects
Paraneoplastic Syndromes
/ etiology
Virus Activation
Hepatitis
Hodgkin
Liver involvement
Lymphoma
Lymphoproliferative disorders
Vanishing bile duct syndrome
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Hepatic abnormalities in patients with lymphoproliferative disorders are common and can occur from direct infiltration by abnormal cells, bile duct obstruction, paraneoplastic syndrome, hemophagocytic syndrome, drug-induced liver injury, opportunistic infections, and reactivation of viral hepatitis. Hepatic involvement by lymphoma is often in association with systemic disease and rarely seen as a primary hepatic lymphoma. Vanishing bile duct syndrome is a well-known complication of Hodgkin disease. Antiviral prophylaxis for hepatitis B virus (HBV) reactivation is recommended for all HBsAg
Identifiants
pubmed: 30947878
pii: S1089-3261(18)30114-4
doi: 10.1016/j.cld.2018.12.010
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-308Informations de copyright
Copyright © 2018 Elsevier Inc. All rights reserved.